Therapeutic area

Immunology

Autoimmune, autoinflammatory, and immune-mediated inflammatory diseases driven by aberrant immune signaling.

Core & active disease programs

Rheumatoid Arthritis

$32.7B attributable cost

$13.4B$ drug spend

61 assets · 1 indication

Psoriatic Arthritis

$27.1B attributable cost

$12.9B$ drug spend

42 assets · 1 indication

Systemic Lupus Erythematosus

$4.5B attributable cost

$1.6B$ drug spend

55 assets · 1 indication

Provisional & emerging programs (12)Early clinical pipeline & single-asset indications

Dermatomyositis

Allergic Conditions

Autoimmune Diseases

Cartilage Defects of the Knee

Graves' Disease

Idiopathic Inflammatory Myopathies

Organ Transplant Rejection

Sjögren's Disease

Systemic Sclerosis

All assets in Immunology